Mad Money: Key points from October 12, 2021 (Tuesday) episode

Home Forums Investments in the US Summary of CNBC “Mad Money” Episodes Mad Money: Key points from October 12, 2021 (Tuesday) episode

  • This topic is empty.
Viewing 0 reply threads
  • Author
    • #4380

      This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, October 12, 2021.  It also contains links to CNBC sites which contain video clips and transcripts are also listed.


      (1) Cramer says the stock market is ‘incredibly confusing’ right now and investors should be patient (

      • CNBC’s Jim Cramer said Tuesday it’s OK for investors to have difficulties wrapping their heads around the stock market right now.
      • The “Mad Money” host encouraged viewers to wait “until we get closer to the end of the month” before buying into weakness.
      • “Don’t feel bad if the market makes you feel baffled. It’s incredibly confusing out there,” he said.

      [Charitable Trust owns COST, AAPL]


      (2) Executive Interview:CEO of cybersecurity firm CrowdStrike says the average ransom payment is $6 million (

      CrowdStrike co-founder and CEO George Kurtz told CNBC’s Jim Cramer on Tuesday that ransomware is a big challenge for companies, with average payments around $6 million.

      Ticker: CRWD


      (3) Off-the-Chart: Charts suggest the oil rally is living on borrowed time, says Jim Cramer (

      • “The charts, as interpreted by Carley Garner, suggest that this oil rally’s living on borrowed time,” CNBC’s Jim Cramer said Tuesday.
      • “Sooner or later, she thinks crude will roll over as privately held producers flood the market with supply,” the “Mad Money” host said.


      (4) Executive Interview: Medtronic CEO discusses the company’s advancements on deep brain stimulation therapies (

      CNBC’s Jim Cramer interviewed Medtronic chairman and CEO Geoff Martha on Tuesday’s episode of “Mad Money.”

      Ticker: MDT


      (5) Cramer’s lightning round: Hold Doximity for the long run (

      • Doximity: “Doximity is, it’s such a great company, up very big today. Here’s the problem with Doximity, that’s the kind of stock that people have turned on. … I think you hold Doximity for the long run. That’s how you make money.”
      • Abbott Laboratories: “That’s the reason why people have been shying away from buying the stock, but they sure aren’t shying away from buying [rapid Covid test] BinaxNOW. I think that this thing is going to be with us for a long time. Remember, they already preannounced bad for BinaxNOW. They’re not preannouncing good, but Abbott’s got so many other things going for it. Let’s not call it a BinaxNOW story. I like Abbott, but I’ve liked it for multiple years and will continue to do so for the charitable trust and, of course, the CNBC Investing Club.”
      • Tilray: “Look, Irwin Simon runs it, used to run Hain. I happen to like him very much. I don’t like the cannabis industry except for the industrial real estate part, which is a REIT. The cannabis industry has just caused a lot of heartache, and between SPACs and cannabis, there are a lot of people who have left our stock market. I don’t want that to happen to you.”
      • Upwork: “Upwork, I mean, it’s like Indeed. These are like recruitment companies that are very important right now. They do it for high and white-collar people. The stock has had its high, but I think it can go higher. It’s not a bad company.”

      Ticker: DOCS, ABT, TLRY, UPWK


      (6) [No Video Clip] The China trade — [Charitable Trust own BA]


      Other Stocks Discussed (Calls with Audiences): Deer (DE), Canadian Solar CSIQ


      Ref: Links to other sites that relate to episode of October 12, 2021



      Previous episode Next Episode


Viewing 0 reply threads
  • The topic ‘Mad Money: Key points from October 12, 2021 (Tuesday) episode’ is closed to new replies.